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Abstract
Background: Slug, Snail, and Twist are transcription factors that regulate the expression of tumor suppressors such
as E-cadherin. In this study, we aimed to examine the expression of these transcription factors in human bladder
carcinoma.
Methods: We first investigated expression of Slug, Snail, Twist and E-cadherin in five bladder Carcinoma cell lines
by reverse transcription-polymerase chain reaction and western blotting. Furthermore, we investigated Slug, Snail,
and Twist and E-cadherin expression by immunohistochemistry with bladder carcinoma (tumor, n = 120;
background, n = 42).
Results: Expression of Slug mRNA and protein was detected in all cell lines, Twist was clearly expressed in two out
of five bladder carcinoma cell lines, Snail was not expressed, and E-cadherin was detected in 3 cell lines. 44.2%
(53/120) of human bladder Carcinoma tissues and 38%(16/42) background tissue showed an expression of Twist;
62.5%(75/120) of human bladder Carcinoma tissues and 40%(17/42) background tissue showed an expression of
Slug, 15.8% (19/120) of human bladder Carcinoma tissues and 76%(32/42) background tissue showed an expression
of Snail, and 25.8% (31/120) cases were negative for E-cadherin expression in carcinoma tissues. Expression of Slug
and Twist shows increased levels in tumors, whereas Snail seems reduced. Statistically significant correlations were
found between Twist, Slug, and E-cadherin expression. Immunohistochemistry analysis showed that Twist was
elevated with increasing tumor stage (P = 0.001), the grade (P < 0.001), the progression (P = 0.035). Slug was
elevated and Snail was reduced with increasing nodal involvement (tumor-node-metastasis status) (P = 0.004, P =
0.01). E-cadherin was reduced in expression corresponding with tumor grade (P < 0.01). Positive Twist, Slug and E-
cadherin expression clearly predicted poorer PFS (P = 0.042, P = 0.014, P = 0.001). In the multivariate analysis, only
Snail and E-cadherin expression were independent prognostic factors for OS (P = 0.002, P < 0.001).
Conclusions: These data demonstrate that Twist, Snail and Slug have inappropriate expression in bladder
carcinoma and that this may play a part in the progression of human bladder carcinoma.
Background
Bladder cancer is the second most common genitourin-
ary tract cancer and the fourth or fifth most common
cancer of men in western industrialized countries[1]. In
China, bladder cancer is the most common malignancy
in genitourinary tract and the fifth most common cancer
in men. Generally, radical cystectomy is considered the
standard treatment for patients with muscle-invasive
tumors, and systemic chemotherapy is the only current
modality that provides the potential for long-term survi-
val in patients with metastatic disease, but the prognosis
of patients with advanced bladder cancer is still extre-
mely poor despite recent therapeutic advances[2]. It is
well known that bladder tumors with the same stage
and grade have a heterogeneous clinicaloutcome as they
are probably molecularly different. The term of superfi-
cial or invasive bladder tumor is confusing as it implies
that only one kind of superficial or invasive bladder can-
cer exists[3]. Understanding the molecular biology of
bladder cancer and metastasis may provide insight for
the development of novel tumor markers or new thera-
peutic strategies.
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as a critical process during cancer progression in which
downregulation or loss of E-cadherin expression (epithe-
lial marker) constitute a molecular hallmark [4,5]. The
transcriptional factors Snail and Slug (zinc finger
proteins) have been described to be direct repressors of
E-cadherin [6-11] in vitro and in vivo through an inter-
action of their COOH-terminal region with a 5′-
CACCTG-3′ sequence in the E-cadherin promoter [12].
Both have been suggested to be involved in the acquisi-
tion of resistance to apoptosis, thereby promoting tumor
survival. Recently, it has been postulated that Twist,
another promoter repressor of CDH1 (E-cadherin gene),
may be involved in tumor progression by silencing E-
cadherin expression and EMT induction [13,14]. Twist
is considered as a promoter of the EMT, which is a key
event in the tumoral invasion step. Up-regulation of
Twist is associated with malignant transformation of
melanoma and T-cell lymphoma [13]. It is possibly
involved in E-cadherin conversion during EMT [14].
Studies in other cancers have shown that overexpression
of Snail and Slug leads to a reduction of E-cadherin
expression. An overexpression of Twist resulted in an a
further decrease of E-cadherin expression [15].
Because Snail, Twist and Slug are potential regulators
of cell adhesion and migration, this study aimed to
determine the levels of expression of Snail, Slug, and
Twist in human bladdert cancer tissues and to elucidate
whether these levels are clinically significant. Also, to
clarify whether the three factors may be used as a novel
parameter to predict prognosis in bladder carcinoma.
Materials and methods
Patients and paraffin-embedded tissue sample
The study included 120 patients with a primary bladder
tumor and 42 background tissue(paracarcinoma tissue,
more than 1.5-2 cm from cancer tissue). The tissues
were obtained from patients who had undergone a
transurethral resection or a partial/total cystectomy
between 1999 and 2002 at the Urology Department, The
affiliated hospital of Qingdao medical college, Qingdao
university, China. None of the patients had received pre-
operative treatment. All patients were classified accord-
ing to the 1997 UICC TNM classification for the stage
and OMS 2004 for the grade (LMP: low malignant
potential; LG: low grade; HG: high grade). Immunos-
taining was evaluated by 2 independent pathologists to
validate the diagnosis. Each sample was used after writ-
ten consent was obtained from the patients. The clinico-
pathological data of the tumors are shown in Table 1.
Tumor recurrence/progression was defined based on
clinical, radiological, or histological diagnoses. The study
was approved by the affiliated hospital of Qingdao
medical college Faculty of Medicine Human Investiga-
tion Committee.
Immunohistochemistry
Immunohistochemical staining was done on paraffin-
embedded tissue, which had described in detail before
[16]. Briefly, three-micrometer-thick sections were cut,
using a rotation microtom. The sections were deparaffi-
nized in xylene and rehydrated in graded alcohols and
distilled water. After antigen retrieval with 0.01% EDTA
(pH 8.0), endogenous peroxidase activity was blocked
with 1% hydrogen peroxide in distilled water for 25 min
followed by washing with distilled water and finally PBS
+ 0.1% Tween for 5 min. To bind nonspecific antigens,
the sections were incubated with 1× Power Block
Table 1 Clinical information of patient samples analyzed
Variable n (%)
Tissue type
Background 42
Tumor 120
Age - yr (mean)
< 70 64 (53)
≥70 56 (47)
Gender - number of patients
Male 87 (72)
Female 33 (28)
Grade - no. of patients
LG 41 (34)
HG 79 (66)
Stage - number of patients (%)
NMIBC:
Ta 31 (26)
T1 45 (37)
MIBC:
T2N0M0 23 (19)
T3 N0M0 19 (16)
T4/Any T N+/M+ 2 (1.6)
Surgical procedure
TUR 76(63)
Cystectomy 44(37)
Recurrence
Number of patients with NMIBC 23(19)
Progression:
Number of patients with NMIBC
8 (6.6)
Number of patients with MIBC 15 (12.5)
Survival Number of patients with MIBC
Cancer-specific
Alive 27 (22.5)
Deceased 17(14)
Overall survival
Alive 25 (21)
Deceased 19 (16)
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Slug, Twist, and E-cadherin were either polyclonal rabbit
anti-Twist and anti-E-cadherin or polyclonal goat anti-
Snail and anti-Slug, and purchased from Santa Cruz
Biotechnology. Antibody dilution ranged from 1:50 to
1:150 in PBS for 30 min at 37°C. As negative control,
sections were incubated with PBS instead of the primary
antibody. This was followed by incubation with biotiny-
lated antirabbit/antigoat immunoglobulin G (1:200;
Santa Cruz Biotechnology) for 30 min at 37°C and per-
oxidase-conjugated avidin-biotin complexes (KPL) and
3,3′-diaminobenzidine (Sigma). The sections were then
counterstained with Mayer’s hematoxylin, upgraded
alcohols, mounted, and analyzed by standard light
microscopy.
Evaluation of immunohistochemistry results
Immunohistochemical staining of Snail, Slug and Twist
and E-cadherin was defined as detectable immunoreac-
tion in perinuclear and/or cytoplasm. Expression of
Snail, Slug and Twist was considered negative when no
or less than 49% of the tumour cells were stained[16].
Cancer cells that were immunostained less than 10%
staining were defined as having a reduced E-cadherin
expression[17].
Cell lines
The human bladder cancer cell lines (T24, HTB-3,
HTB-1, HTB-2 and HTB-9) obtained from ATCC
(Rockville, MD, USA). All the cell lines were maintained
in RPMI 1640 medium supplemented with 10% FCS, 1%
penicillin and streptomycin at 37°C in 5% CO2.
Reverse transcription-polymerase chain reaction
Total RNA from the cell lines were obtained using
RNeasy Mini kit(Qiagen, Tokyo, Japan) according to the
manufacture’s instructions and resuspended in 50 μL
dimethylpyrocarbonate-treated water. RNA concentra-
tion was determined using a BioPhotometer (Eppendorf
Scientific). Total RNA (2 μg) was primed with an oligo
(dT) oligonucleotide and reverse transcribed with
M o l o n e ym u r i n el e u k e m i av i r u sr e v e r s et r a n s c r i p t a s e
(Promega) and deoxynucleotide triphosphates (Sigma-
Aldrich) according to the instructions of the
manufacturer. First-strand cDNA was amplified with
transcript-specific oligonucleotides using Ready-Mix Taq
PCR Reaction Mix (Sigma-Aldrich). The primers (TIB
Molbiol) for the respective genes were designed as fol-
lows: Slug (533 bp) 5′-GGTCAAGAAGCATTTCAAC-3′
(sense) and 5′-GGTAATGTGTGGGTCCGA-3′ (anti-
sense);Snail (557 bp) 5′-CAACCCACTCAGATGTCAA-
3′ (sense) and 5′-CATAGTT AGTCACACCTCGT-3′
(antisense); Twist (527 bp) 5′-GGGAGTCCGCAGTCT-
TAC-3′ (sense)and5′-CCTGTCTCGCTTTCTCTTT-3′
(antisense); E-cadherin (420 bp)5′-ATTC TGAT
TCTGCTGCTCTTG-3′ (sense)and 5′-AGTAGTCATAG
TCCTGGTCTT-3′(antisense);and b-actin (335 bp) 5′-
TTCCTGGGCATGGAGTCCTGTGG-3′ (sense) and 5′-
CGCCTAGAAGCATTTGCGGTGG-3′ (antisense). The
condition of PCR for Slug were: initial denaturing at 95°
C for 10 min, followed by 38 cycles of denaturing at 94°
C for 60 s, annealing at 53°C for 60 s and extension at
72°C for 90 s. All PCR products were visualized by elec-
trophoresis and ethidium bromide staining in 2% agar-
ose gels. RT-PCR was performed in a triplicate.
Western blotting analysis
For isolation of total protein, cells were washed twice
with ice-cold PBS containing phosphatase inhibitor
cocktail II (Sigma-Aldrich), scraped of the culture flask,
pelleted by centrifugation, and lysed in buffer containing
10 mmol/L Tris (pH 6.8), 2 mmol/L EDTA (pH 8.0),
0.15 mol/L NaCL, 0.1% Brij 96, 0.1% NP40, 2 mmol/L
phenylmethylsulfonyl fluoride, and 1× Protease inhibitor
cocktail (Sigma-Aldrich). Protein was estimated using
QuantiPro bicinchoninic acid assay kit (Sigma-Aldrich)
according to the instructions of the manufacturer[16].
Ten micrograms of proteins were denatured at 95°C
with sample buffer [0.125 mol/L Tris (pH 6.8), 4% SDS,
20% glycerol, 2% mercaptoethanol, 0.03 mmol/L brom-
phenol blue] for 5 min and separated by electrophoresis
in 7.5% to 12% SDS-PAGE gels according to their mole-
cular weight. Proteins were transferred onto a polyviny-
lidene difluoride membrane (Perkin-Elmer) and blocked
for 2 h in blocking solution (5% nonfat dry milk in TBS
containing 0.1% Tween 20) followed by 5% bovine
serum albumin in TBS/Tween at room temperature on
ar o t a t i n gp l a t ef o r2h .T h em e m b r a n ew a st h e n
exposed to the primary antibody overnight at 4°C. The
primary antibodies were the same we used for immuno-
histochemistry, and the dilution was 1:200 in Snail, Slug,
Twist, and E-cadherin, and 1:500 in b-actin. After wash-
ing, the membranes were incubated for 1.5 h at room
temperature with peroxidase-linked secondary antibody
(Roche), and signals were detected using Lumilight Plus
Western blotting kit reagents (Roche) according to the
manufacturer’s instructions and luminescence imaging
(LAS-1000, Fujifilm).
Statistical analysis
We used the c
2 and Fisher’se x a c tt e s t st oe v a l u a t et h e
differences of staining of E-cadherin and Snail, Slug and
Twist according to patient and cancer characteristics.
The overall survival was defined as the time between
t h ed a t eo fs u r g e r ya n dt h el a s td a t eo ff o l l o w - u po r
date to death owing to bladder cancer. The progression-
free survival was defined as the time interval between
t h ed a t eo fs u r g e r ya n dt h ed a t eo fp r o g r e s s i o n
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done using the Kaplan-Meier method with the log-rank
test to assess the statistical significance. Cox propor-
tional hazards analysis was used to determine the rela-
tive contribution of various factors to the risk of death,
recurrence, and progression. P < 0.05 was considered as
statistically significant. Analyses were performed with
SPSS 10.00 software (SPSS, Chicago, IL).
Results
Expression of Snail, Slug, Twist and E-cadherin in human
bladder cancer cell lines
The expression of Snail, Slug, Twist and E-cadherin was
analyzed at the mRNA and protein level by semiquanti-
tative RT-PCR(Fig. 1A) and western blot (Fig. 1B) in the
human bladder cancer cell lines T24, HTB-3, HTB-1,
HTB-2 and HTB-9. Slug was expressed with different
intensities in all five cancer cell lines. The undifferen-
tiated HTB-1 and T24 cells had a strong mRNA and
protein expression of Slug, whereas the other 3 cell lines
showed only weak expression levels. Twist mRNA and
protein was detected in HTB-1 and T24 cells, no
appearant Twist mRNA and protein expression was
found in other 3 cell lines. E-cadherin was detected in
HTB-2, HTB-9 and HTB-3 cell lines. The most undiffer-
entiated cell line HTB-1 and T24 cells showed no E-
cadherin expression. Snail was not detectable in all five
cancer cell lines. To verify intact RNA and protein, b-
actin was used as a positive control.
Expression of Snail, Slug, and Twist in correlation with E-
cadherin in human bladder cancer tissue
Slug(A), Twist(B, F), Snail (Fig. 2C and 2G) in primary
bladder cancer tissue were identified in the cytoplasm as
well as in the nucleus of cancer cells. In general, stain-
ing for Slug and Twist was more intense than for Snail.
E-cadherin expression in cancer cells was characterized
by patterns with variable degrees of cytoplasmatic and
membrane staining (Fig. 2D).
Immunohistochemistry showed that 44.2% (53/120) of
human bladder carcinoma tissues and 38%(16/42) back-
ground tissue(G) expressed Twist(P = 0.156);62.5%(75/
120) of human bladder Carcinoma tissues and 40%(17/
4 2 )b a c k g r o u n dt i s s u e ( F i g .2 E )e x p r e s s e dS l u g ( P=
0.044); 15.8% (19/120) of human bladder carcinoma tis-
sues and 76%(32/42) background tissue(Fig. 2F)
expressed Snail(P = 0.016) and 25.8% (31/120) cases
were low for E-cadherin expression in carcinoma tissues
(Table 2). More patients with high Slug and Twist
expression displayed low E-cadherin expression. Statisti-
cally significant correlations were found between Twist,
Slug, and E-cadherin expression. No statistically signifi-
cant correlations were found between Snail and E-cad-
herin expression(Table 3).
Correlation between Snail, Slug, Twist and E-cadherin and
clinicopathological parameters
There was a significant correlation between Twist over-
expression and the tumor stage (P = 0.000)and grade
(P = 0.000): superficial BT (Ta-1) (19 out of 76: 25%)
Figure 1 Expression of Snail, Slug and Twist in five bladder
cancer cell lines T24, HTB-1, HTB-2, HTB-3 and HTB-9. The
analysis of the relative mRNA and protein intensity of Slug, Snail
and Twist compared with E-cadherin showed that bladder cancer
cells with a high Slug and Twist expression had no or only low E-
cadherin expression. In contrast, cells with low Slug and Twist
expression had high expression levels of E-cadherin.
Figure 2 Expression of Slug, Twist, Snail and E-cadherin in
human bladder cancer and bankground tissue was determined
by immunohistochemistry. Staining of Snail(A), Slug(B), and Twist
(C) was found in the cytoplasm as well as in the nucleus of tumor
cells. Magnification, ×200. E-cadherin (D)expression was identified in
the cell membrane and intensive in the cytoplasm. Magnification,
×200. No expression of Slug in bankground tissue(E), strong of Twist
and Snail expression in bankground tissue (F-G).
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of 41:19.51%), and HG (45 out of 79: 56.96%). The
Twist immunoreactivity categorized into negative (< 2%
of positive cells) vs. high expression was associated with
several clinicopathological parameters: stage, grade, car-
cinoma in situ (CIS), progression(Table 3). In the pT1
BT group, the high-risk pT1b (lamina propria invasion)
showed a Twist overexpression almost similar to inva-
sive BT, explaining that the prognostic of both types of
tumor is quite the same(date not showed). Of the 120
BT specimens, we demonstrated no correlation between
Slug and Snail expression and stage and grade, but we
demonstrated a correlation between E-cadherin expres-
sion and grade (p = 0.017): LMP (17 out of 18: 94.44%),
LG (25 out of 41: 60.98%), and HG(64 out of 79:
81.01%) (Table 4). Only Twist was associated with clini-
copathological parameters as progression(p = 0.035)
(Table 4). It is interesting to note that Slug, Snail and E-
cadherin had increased expression in node-positive
tumors compared with node-negative tumors, these data
reached significance(P = 0.012, P = 0.000, P = 0.040),
respectively (Table 4). Twist was increased in node-posi-
tive tumors (node positive,10/18; node negative,43/102 p
= 0.291), although the value was not significantly
different.
Correlation between proteins expression and BT
recurrence
During the follow-up period (median follow-up time 30
months (1-89), the total number of cases in which
recurrence was observed is 36(30%) between 2 to 62
months after initial diagnosis. We failed to demonstrate
any significant association between this event and the
clinicopathological data tested or the Slug, Twist, Snail
and E-cadherin expression. Even in the univariate and
multivariate analyses.
Correlation of proteins expression with survival of
patients with BT-Univariate analysis
Snail, Slug, Twist and E-cadherin is suggested to have a
critical impact on progression and metastasis develop-
ment as it positively influences the entrance of the
tumor cells into the circulation (intravasation)[18-22].
To investigate the progression-free survival(PFS) or the
overall survival (OS), we defined a time point of 36
months. During the time study, the 3-year PFS rates of
patients who were positive (n = 53) and negative
(n = 67) for Twist expression were 40% and 60%, posi-
tive (n = 75) and negative (n = 45) for Slug expression
were 61% and 39%, and positive (n = 19) and negative
(n = 101) for Snail expression were 15% and 85%,
respectively (Table 4). In univariate analysis, positive
expression of Twist, Snail and loss of E-cadherin expres-
sion, the stage, the grade, and CIS were significant pre-
dictors of short PFS. But positive expression of Slug was
not significant predictors of short PFS(Table 5). For the
3-year OS rates, patients with Slug overexpression
represented 34% and patients without,66%, patients with
Twist overexpression represented 36% and patients
without, 64%, and patients with Snail overexpression
represented 18% and patients without, 82%(Table 5).
Loss of E-cadherin expression, stage, grade, and CIS
were also negative predictors of the OS (Table 5). We
failed to demonstrate any significant correlation between
OS and Twist, Slug and Snail,(Table 5).
Multivariate analysis of prognostic variables in patients
with BT
In this analysis, we only focused on markers of interest
in this study. Doing a multivariate analysis with too
many variables, even in 120 patients with BT, is bio-sta-
tistical nonsense. As stage, grade, or CIS are well-known
prognostic factors in BT, we evaluated the expression of
Snail, Slug, Twist and E-cadherin. In multivariate PFS
analysis, Snail, Slug, Twist and E-cadherin were entered
into the Cox proportional hazard analysis. Only Twist,
Slug and E-cadherin expression retained significance as
a prognostic factor of a short PFS (OR, 0.276; 95% CI,
0.090-0.841; P = 0.018, OR, 0.656, 95% CI, 0.215-2.003;
P = 0.014, and OR, 23.208, 95% CI, 6.113-3.331; P =
Table 2 Expression and Snail, Slug, Twist and E-cadherin
in bladder cancer and background tissue
Variables Positive
expression (n)
Low
expression (n)
x
2 P
Slug 6.150 0.013
Cancer(120) 75 45
Background(42) 17 25
Snail 52.542 < 0.000
cancer(120) 19 101
Background(42) 32 10
Twist 0.469 0.493
cancer(120) 53 67
Background(42) 16 26
Table 3 Correlation between E-cadherin expression and
Snail, Slug, and Twist expression in 120 cases of bladder
cancer
E-cadherin expression(n) X
2 P
Slug expression(n) +(n = 89) -(n = 31)
+(n = 75) 64 11 13.016 0.000
-(n = 45) 25 20
Twist expression(n)
+(n = 53) 46 7 7.898 0.005
-(n = 67) 43 24
Snail expression(n)
+(n = 19) 11 8 3.523 0.061
-(n = 101) 79 22
Yu et al. Journal of Experimental & Clinical Cancer Research 2010, 29:119
http://www.jeccr.com/content/29/1/119
Page 5 of 90.000, respectively (Table 6). In multivariate OS analysis,
only Slug and E-cadherin expression was an indepen-
dently significant prognostic factor (OR, 0.409;95% CI,
0.017-0.140; P = 0.000; OR, 3.435;95% CI, 1.421-8.305,
P = 0.005) (Table 6).
Discussion
Recent studies have shown the role of Snail and Slug as
strong repressors of E-cadherin gene expression in var-
ious cancer cell lines, including esophageal adenocarci-
noma, lung, breast, endometrioid adenocarcinomas
hepatoma HepG2 and human extrahepatic hilar cholan-
giocarcinoma, thus inducing tumor malignancy[23-28].
In addition, Twist is up-regulated in several types of
epithelial cancers, including esophageal adenocarcinoma,
malignant parathyroid neoplasia, hepatocellular carci-
noma [29-31].
In our study, we have shown that the expression of
Snail and Slug was significantly increased in human BT
tissue than that of in background tissue. Moreover, the
patients with strong E-cadherin expression showed no
or less staining of Slug and Snail. A correlation between
expression levels of Slug and E-cadherin was obvious in
these human specimens(P = 0.013). which confirmed a
previous study [32]. However, expression of Snail in BT
showed no significant relation to the expression of E-
cadherin. We have also shown that more patients with
high Twist (46/53)expression displayed low E-cadherin
expression (7/67), and high E-cadherin expression(43/
67) displayed low Twist expression(24/53) in human BT
tissue. There was an inverse relationship between Twist
overexpression and loss of E-cadherin expression (P =
0.005), which confirmed a previous study [33,34]. We
further studied the expression of Snail, Slug, Twist, E-
cadherin in well established human BT cell lines. At the
mRNA and protein level, BT cells with a high Slug and
T w i s te x p r e s s i o nh a dn oo ro n l yw e a kE - c a d h e r i n
expression, whereas no expression of Snail in BT cells
was seen. Snail did not repress E-cadherin, neither at
the RNA nor at the protein level. Comparing the
expression levels of Twist, Slug and E-cadherin, there is
evident that Slug and Twist is the strong repressor of E-
Table 4 Relationship between the expression of Slug, Twist, Snail and E-cadherin and clinicopathological parameters
in human bladder cancer
Patients Slug Twist Snail E-cadherin
Variables n +- p +- p +- p +- p
Sex 0.493 0.557 0.664 0.824
Male 87 56 31 37 50 13 74 65 22
Female 33 19 14 16 17 6 27 24 9
Age (years) 0.257 0.523 0.947 0.845
≤ 70 64 43 21 30 34 10 54 47 17
> 70 56 32 24 23 33 9 47 42 14
Stage 0.171 0.000 0.986 0.874
pTa, pT1 76 51 25 19 57 12 64 56 20
≥PT2 44 24 20 34 10 7 37 33 11
Grade 0.082 0.000 0.789 0.017
LG 41 30 11 8 33 7 34 25 16
HG 79 45 34 45 34 12 67 64 15
Nodal involvement 0.012 0.291 0.000 0.040
yes 18 16 2 10 8 13 5 17 1
no 102 59 43 43 59 6 96 72 30
Recurrence(n = 76) 0.483 0.242 0.931 0.719
yes 23 15 8 12 11 5 18 16 7
no 53 30 23 20 33 12 41 39 14
Progression A(n = 76) 0.124 0.021 1.000 1.000
y e s 8 3 56 23 57 1
no 68 46 22 21 47 27 41 55 13
Progression B(n = 44)
yes 15
no 29
Death C(n = 44) 0.760 0.754 0.748 0.509
yes 17 9 8 11 6 5 12 13 4
no 27 16 11 15 12 10 17 17 10
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Slug and Twist completely repressed E-cadherin (Fig. 1).
With increasing differentiation, Slug and E-cadherin or
Twist and E-cadherin were coexpressed in BT cells (Fig.
1). This agrees with the fact that Slug and Twist is
expressed at higher levels in poorly differentiated pan-
creatic cancer cell lines and that these tumors are more
likely to grow invasive [35,36]. In contrast to Twist and
Slug, Snail showed no expression in 84.2% of human BT
tissues and in all five human BT cell lines. This was an
interesting fact because several studies have shown an
overexpression of Snail in a variety of different tumors
[18,19,37]. However, the mechanism(s)involved therein
have not been examined so far in BT.
Many studies have showed that Twist, Slug and Snail
expression is related to the invasive proliferation of
tumors and to be a poor prognostic factor in various
human tumors. Our results showed that Twist expresse
in human BT tissues was significantly correlated to the
tumor stage, grade and progression (P = 0.000, P =
0.000 and P = 0.021, respectively);Snail was significantly
correlated to nodal involvement (P = 0.000), but Snail
was not involved in bladder tumor differentiation, stage,
grade and progression;Slug was only significantly corre-
lated to nodal involvement (P = 0.012). It would seem
unnecessary to evaluate new progression marker in the
very aggressive group of invasive BT of which the prog-
nosis is pejorative, but the comparison of the molecular
profile between superficial and invasive BT could allow
individualizing a molecular marker of interest in order
to treat earlier and more efficiently the high-risk of pro-
gression superficial bladder tumor. However, it has been
demonstrated in human tumor cell lines that the forced
expression of E-cadherin was not sufficient to reverse
the process in Slug, Snail or Twist-expressing cells, and
this result supports that Slug, Snail or Twist might mod-
ulate other important signaling pathways involved in
tumor progression and metastasis development
Table 5 Univariate analyses of various clinicopathological parameters in relation to survival of patients with bladder
tumor
Variables Patients Progression-free survival(PFS) Overall survival(OS)
(n = 120) 5-year survival (%) (n = 103) P-Value 5-year survival (%) (n = 61) P-Value
Sex 0.051 0.363
Male 87 78(75.7%) 42(68.9%)
Female 33 25(24.3%) 19(31.1%)
Age (years) 0.108 0.591
≤ 70 64 58(56%) 34(55%)
> 70 56 45(44%) 27(45%)
Stage 0.175 0.016
pTa-T1 76 6871.8% 45(74%)
≥PT2 44 3528.2% 16(26%)
Grade 0.008 0.018
LG 41 40(38.8%) 27(38%)
HG 79 63(61.2%) 34(62%)
Slug 0.457 0.479
+ 75 63(61%) 40(66%)
- 45 40(39%) 21(34%)
Twist 0.018 0.069
+ 53 41(40%) 22(36%)
- 67 62(60%) 39(64%)
Snail 0.732 0.502
+ 19 16(15%) 11(18%)
- 101 87(85%) 50(82%)
E-cadherin 0.000 0.005
+ 89 86(83.5%) 52(85%)
- 31 17(16.5%) 9(15%)
Table 6 Multivariate analyses of Snail, Slug, Twist and
E-cadherin
Variables Progression-free survival Overall survival
OR (95% CI) P-Value OR (95% CI) P-Value
Slug 0.656 (0.215-2.003) 0.457 0.409 (0.017-0.140) 0.000
Twist 0.276(0.090-0.841) 0.018 0.510(0.245-1.058) 0.069
Snail 0.858(0.221-3.777) 0.891 1.403(0.521-3.777) 0.502
E-cadherin 23.608(6.113-3.331) 0.000 3.435(1.421-8.305) 0.005
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Page 7 of 9independently of E-cadherin expression[38-42]. Then, it
strengthens the argument to justify both Slug or Snail
or Twist expression and potential downstream targets as
E-cadherin expression evaluation.
It has already been demonstrated that Slug, Snail or
Twist overexpression was associated with poor outcome
and shorter survival in patients with solid tumors
[31-34]. Our findings support this hypothesis as E-cad-
herin and Twist expression were associated with poor
survival both in univariate andm u l t i v a r i a t ea n a l y s e so f
all factors that influenced survival.
Franck Bruyere et al.[43]have found that high expres-
sion of Snail in superficial bladder tumors significantly
predicts tumor recurrence in these patients. But we did
not find any relationship between the expression of
Snail and tumor recurrence. That we had a different
way to evaluate the immunohistochemistry results may
be the reasons.
The univariate analysis showed that high Snail expres-
sion, histologic grading, CIS and E-cadherin(P =0 . 0 0 5 )
were statistically significant risk factors. The backward
stepwise multivariate analysis showed that high Snail
and Slug expression and E-cadherin were statistically
significant independent risk factors. One mechanism of
the link between Slug, Snail or Twist expression and
poor prognosis may be the reducing of E-cadherin
expression allowing cancer cells to migrate but it is
probably not the only one[38-42].
Moreover, in our study, we noticed that some patients
with high-risk superficial bladder tumors that High
expressed Slug, Snail or Twist displayed distant metasta-
sis within 2 years after initial diagnosis even if a cystect-
omy was performed. We also noticed that among
patients who benefited from a cystectomy for invasive
bladder tumor, 10/18 had lymph node metastasis with a
bladder tumor high expressing Slug, Snail or Twist and
without E-cadherin expression. These results suggest
that although the prognostic value of Slug, Snail or
T w i s ts h o u l db ec o n f i r m e di nal a r g e rn u m b e ro f
patients, its expression could be a useful marker for
selecting patients with a high risk of a poor clinical out-
come and for proposing a better therapy to them.
The inhibition of Slug, Snail or Twist action through
interfering RNA (siRNA)or antisense transfer resulted in
tumor metastasis or growth inhibition and increased
sensitivity to the cytotoxic agents used in chemotherapy
for solid cancers [29,44-46]These results strongly sug-
gest the relation between EMT markers induction
including Slug, Snail and Twist but also between anti-
Slug, Snail or Twist treatment and improvement of
bladder cancer chemotherapy.
In conclusion, the EMT regulatory proteins Slug and
Twist are upregulated in human BT, whereas Snail is
downregulated. Such disparate expression levels may
contribute to the progression of tumors in BT, and this
deserves further investigation. Our results highlighted
the potential role of Twist, Snail and Slug as the prog-
nostic factor in bladder cancer. They could be a very
useful molecular marker of progression in BT. If our
findings are validated by additional studies, Slug, Snail
and Twist expression could be used as a predictive fac-
tor in bladder cancer but also as a novel target for clini-
cal therapy. Identifying new molecular markers could
also be the first step to accurately define a high risk-of-
progression molecular profile in BT.
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